(Q39408230)

English

Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokinetics

scientific article published on April 2002

Statements

Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokinetics (English)
Michael A Carducci
Joel B Nelson
M Kathy Bowling
Theresa Rogers
Mario A Eisenberger
Victoria Sinibaldi
Ross Donehower
Terri L Leahy
Robert A Carr
Jeffrey D Isaacson
Todd J Janus
Amy Andre
Balakrishna S Hosmane
Robert J Padley
1 April 2002
2171-2180

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit